03.04.2023 Hannover Medical School (MHH) has cracked the 100 million euro mark in third-party funding spent for the first time in its 58-year history. In 2022, researchers used a total of 101.4 millio

MD/PhD program Molecular Medicine Fully accreditated in 2009 as the first PhD program in Germany according to European standards (ECTS), the MD/PhD program features an interdisciplinary curriculum lea

Dr. Hristo Georgiev Institute of Immunology, OE 5240 I11-02-1120 Phone: +49 511 532 9729 E-Mail: Georgiev.Hristo @ mh-hannover.de Research Focus The basic research interest of our group includes the d

20.03.2023 Pulmonary arterial hypertension (PAH) is a special form of pulmonary hypertension. It occurs because the small arteries in the lungs narrow as a result of progressive changes in the blood v

16.03.2023 In Germany, 270,000 people suffer a stroke every year. This can result in severe disabilities: Paralysis, speech disorders and problems walking. Often, it does not remain a one-time event.

Chief of the Department Prof. Dr. med. Kai Schmidt-Ott Curriculum Vitae Prof. Dr. med. Kai Schmidt-Ott Prof. Dr. Kai Schmidt-Ott is Chief of the Department of Nephrology and Hypertension at Hannover M

15.03.2023 Preliminary stages of cervical cancer occur mainly in women between 25 and 35 years of age. The main risk factor for developing cervical cancer is the human papillomavirus (HPV). Surgery is

15.03.2023 What does a switch actually do? What conducts electricity and what doesn't? How many insects live on the grounds of the daycare center? Why does the street get so hot in the summer? And how

Members of the Georgiev Group Hristo Georgiev Georgiev.Hristo @ mh-hannover.de Phone: +49 511 532 9729 Hristo is interested in investigating the mechanisms controlling development and differentiation

Completed Projects of the Georgiev Group 05/2018 – 04/2020 Research Stipends GE 3062/1-1 Deciphering endogenous and environmental factors impacting on development and function of iNKT cell subsets.